Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Cardiorenal syndrome type 4 (CRS type 4), or chronic renocardiac syndrome, describes chronic kidney disease (CKD) leading to cardiac disease.
• CKD is a significant and prevalent risk factor for cardiovascular disease (CVD).
• Cardiovascular disease accounts for up to 50% of deaths in patients with CKD, highlighting a critical clinical challenge.

Purpose of the Study:

• To review conventional and non-conventional cardiovascular disease (CVD) risk factors associated with chronic kidney disease (CKD).
• To emphasize the importance of evaluating and managing these risks in patients with CKD.
• To underscore the substantial healthcare burden posed by CRS type 4.

Main Methods:

• Literature review focusing on established and emerging CVD risk factors in CKD patients.
• Analysis of the relationship between renal function abnormalities and cardiac disease development.
• Synthesis of current understanding regarding the management of cardiovascular risks in CKD.

Main Results:

• CKD significantly increases the risk of developing cardiovascular disease.
• Effective management of cardiovascular risk factors is essential for improving prognosis in CKD patients.
• CRS type 4 represents a major health concern due to the high mortality associated with CVD in this population.

Conclusions:

• Chronic kidney disease is a potent driver of cardiovascular disease, defining Cardiorenal Syndrome Type 4.
• Thorough assessment and management of cardiovascular risks are imperative for patients with CKD.
• Addressing these risks is vital for reducing mortality and healthcare burden.